Georgia Erbez
CIK 1557930 · See Remarks · last filed 2026-02-25
Georgia Erbez is a corporate insider who has filed 28 SEC Form 4 insider transactions across 8 companies since 2012. The most recent filing, for CDXS, was dated Feb 25, 2026. Across all open-market trades the lifetime net is +$311.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $160.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$160.3K
8
28
$311.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDXS | See Remarks | 66,810 | $2.40 | $160.3K | -$20.6K | 5 | 2026-02-25 |
| CHRS | Director | — | $1.40 | — | $0 | 3 | 2025-06-13 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | — | $54.99 | — | $0 | 2 | 2022-07-01 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | Chief Financial Officer | 91,507 | $23.01 | $2.11M | $279.0K | 10 | 2022-02-01 |
| ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Director | — | $0.01 | — | $0 | 1 | 2019-08-30 |
| Zosano Pharma Corp (ZSAN) Delisted | CFO and Chief Business Officer | 115,750 | $0.56 | $64.5K | $152.8K | 3 | 2017-05-25 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | Exec VP & CFO | — | — | — | $0 | 1 | 2015-11-12 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Chief Financial Officer | 2,500 | — | — | -$99.3K | 3 | 2014-02-11 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-25 | CDXS | Grant (A) | — | $0 | EDGAR |
| 2026-02-09 | CDXS | Sell (S) | −3,826 | -$5.0K | EDGAR |
| 2025-10-15 | CDXS | Sell (S) | −6,239 | -$15.6K | EDGAR |
| 2025-06-13 | CHRS | Grant (A) | — | $0 | EDGAR |
| 2025-02-07 | CDXS | Grant (A) | +26,875 | $0 | EDGAR |
| 2024-10-10 | CDXS | Grant (A) | +50,000 | $0 | EDGAR |
| 2024-06-05 | CHRS | Grant (A) | — | $0 | EDGAR |
| 2024-02-22 | CHRS | Grant (A) | — | $0 | EDGAR |
| 2022-07-01 | Sierra Oncology, Inc. (SRRA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-02-01 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |